Ming-li Sun
Beijing, 100038, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 11 publications
Corrigendum to "Metformin-mediated protection against doxorubicin-induced cardiotoxicity" [Biomed. Pharmacother., 180, (2024), 117535].
Journal: Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie
Published: April 28, 2026
Reliability of Metformin's protective effects against doxorubicin-induced cardiotoxicity: a meta-analysis of animal studies.
Journal: Frontiers in pharmacology
Published: May 21, 2024
Metformin-mediated protection against doxorubicin-induced cardiotoxicity.
Journal: Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie
Published: March 14, 2024
Development and Validation of a Prediction Model for Venous Thrombus Embolism (VTE) in Patients With Colorectal Cancer.
Journal: Technology in cancer research & treatment
Published: November 29, 2023
Bioequivalence and Safety Assessment of 2 Formulations of Low-Dose Metformin Hydrochloride under Fasting Conditions in Healthy Chinese Participants: A Randomized Phase 1 Clinical Trial.
Journal: Clinical pharmacology in drug development
Published: August 14, 2023
Effects of food on pharmacokinetics and safety of metformin hydrochloride tablets: A meta-analysis of pharmacokinetic, bioavailability, or bioequivalence studies.
Journal: Heliyon
Published: April 02, 2023
Congenital thrombophilia in East-Asian venous thromboembolism population: a systematic review and meta-analysis.
Journal: Research and practice in thrombosis and haemostasis
Published: March 22, 2023
Percutaneous transluminal pulmonary angioplasty for Takayasu arteritis-associated pulmonary hypertension: A single-arm meta-analysis.
Journal: Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions
Published: February 14, 2023
Bioequivalence and safety evaluation of two preparations of metformin hydrochloride sustained-release tablets (Boke® and Glucophage®-XR) in healthy Chinese volunteers: a randomized phase I clinical trial.
Journal: Annals of medicine
Published: September 22, 2022
Bioequivalence and Safety Assessment of Two Formulations of Metformin Hydrochloride Sustained-Release Tablets (Yuantang® SR and Glucophage® XR) Under Fed Conditions in Healthy Chinese Adult Subjects: An Open-Label, Two-Way Crossover, Sequence Randomized Phase I Clinical Trial.
Journal: Drugs in R&D
Published: December 13, 2021
Metformin With or Without Clomiphene Citrate Versus Laparoscopic Ovarian Drilling With or Without Clomiphene Citrate to Treat Patients With Clomiphene Citrate-Resistant Polycystic Ovary Syndrome: A Systematic Review and Meta-Analysis.
Journal: Frontiers in pharmacology
Published: September 04, 2020
Showing 1-11 of 11
Last Updated: 09/26/2026